TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS
Management of Indolent and Smoldering SM is focused on preventing anaphylactic reactions, identifying and avoiding symptom triggers. Skin and gastrointestinal symptoms are managed with H1- and H2-antihistamines. When skin symptoms are not adequately controlled, leukotriene antagonists and oral psor...
Main Authors: | Alessandro Buonomo, Eleonora Nucera, Marianna Criscuolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2022-04-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/4961 |
Similar Items
-
Mastocytosis: One Word for Different Diseases
by: Marianna Criscuolo, et al.
Published: (2018-10-01) -
Systemic Lymphadenopathic Mastocytosis with Eosinophilia
by: Soyoung Im, et al.
Published: (2022-12-01) -
A case of indolent systemic mastocytosis responding to treatment with Avapritinib
by: Terrence Sun, et al.
Published: (2024-02-01) -
Primary cicatricial alopecia associated with systemic indolent mastocytosis
by: Sonya Prasad, BA, et al.
Published: (2020-02-01) -
Delayed Diagnosis of Indolent Systemic Mastocytosis as the Cause of Unexplained Skin Rash: A Case Report
by: Awni Alshurafa, et al.
Published: (2023-02-01)